Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. 2007

Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
Inserm, U768, Paris F-75015, France.

B-cell intrinsic immunoglobulin class switch recombination (Ig-CSR) deficiencies, previously termed hyper-IgM syndromes, are genetically determined conditions characterized by normal or elevated serum IgM levels and an absence or very low levels of IgG, IgA, and IgE. As a function of the molecular mechanism, the defective CSR is variably associated to a defect in the generation of somatic hypermutations (SHMs) in the Ig variable region. The study of Ig-CSR deficiencies contributed to a better delineation of the mechanisms underlying CSR and SHM, the major events of antigen-triggered antibody maturation. Four Ig-CSR deficiency phenotypes have been so far reported: the description of the activation-induced cytidine deaminase (AID) deficiency (Ig-CSR deficiency 1), caused by recessive mutations of AICDA gene, characterized by a defect in CSR and SHM, clearly established the role of AID in the induction of the Ig gene rearrangements underlying CSR and SHM. A CSR-specific function of AID has, however, been detected by the observation of a selective CSR defect caused by mutations affecting the C-terminus of AID. Ig-CSR deficiency 2 is the consequence of uracil-N-glycosylase (UNG) deficiency. Because UNG, a molecule of the base excision repair machinery, removes uracils from DNA and AID deaminates cytosines into uracils, that observation indicates that the AID-UNG pathway directly targets DNA of switch regions from the Ig heavy-chain locus to induce the CSR process. Ig-CSR deficiencies 3 and 4 are characterized by a selective CSR defect resulting from blocks at distinct steps of CSR. A further understanding of the CSR machinery is expected from their molecular definition.

UI MeSH Term Description Entries
D003564 Cytidine Deaminase An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Cytidine Aminohydrolase,Aminohydrolase, Cytidine,Deaminase, Cytidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D017578 Immunoglobulin Class Switching Gene rearrangement of the B-lymphocyte which results in a substitution in the type of heavy-chain constant region that is expressed. This allows the effector response to change while the antigen binding specificity (variable region) remains the same. The majority of class switching occurs by a DNA recombination event but it also can take place at the level of RNA processing. Class Switching,Ig Class Switching,Isotype Switching,Class Switching, Ig,Class Switching, Immunoglobulin,Class Switchings,Class Switchings, Ig,Class Switchings, Immunoglobulin,Ig Class Switchings,Immunoglobulin Class Switchings,Isotype Switchings,Switching, Class,Switching, Ig Class,Switching, Immunoglobulin Class,Switching, Isotype,Switchings, Class,Switchings, Ig Class,Switchings, Immunoglobulin Class,Switchings, Isotype
D051981 Uracil-DNA Glycosidase An enzyme that catalyzes the HYDROLYSIS of the N-glycosidic bond between sugar phosphate backbone and URACIL residue during DNA synthesis. Ung DNA Glycosylase,Ura-DNA Glycosidase,Ura-DNA Glycosylase,Uracil DNA Glycosylase,Uracil N-Glycosidase,Uracil N-Glycosylase,Uracil-DNA Glycosylase,DNA Glycosylase, Ung,DNA Glycosylase, Uracil,Glycosidase, Ura-DNA,Glycosidase, Uracil-DNA,Glycosylase, Ung DNA,Glycosylase, Ura-DNA,Glycosylase, Uracil DNA,Glycosylase, Uracil-DNA,N-Glycosidase, Uracil,N-Glycosylase, Uracil,Ura DNA Glycosidase,Ura DNA Glycosylase,Uracil DNA Glycosidase,Uracil N Glycosidase,Uracil N Glycosylase
D053306 Hyper-IgM Immunodeficiency Syndrome A rare inherited immunodeficiency syndrome characterized by normal or elevated serum IMMUNOGLOBULIN M levels with absence of IMMUNOGLOBULIN G; IMMUNOGLOBULIN A; and IMMUNOGLOBULIN E. It results in a profound susceptibility to BACTERIAL INFECTIONS and an increased susceptibility to OPPORTUNISTIC INFECTIONS. Several subtypes of hyper-IgM immunodeficiency syndrome exist depending upon the location of genetic mutation. Hyper-IgM Immunodeficiency Syndrome, Type 2,Hyper-IgM Immunodeficiency Syndrome, Type 3,Hyper-IgM Immunodeficiency Syndrome, Type 5,HIGM2 Syndrome,HIGM3 Syndrome,HIGM5 Syndrome,Hyper-IgM Immunodeficiency Syndrome Type 2,Hyper-IgM Immunodeficiency Syndrome Type 3,Hyper-IgM Immunodeficiency Syndrome Type 5,Hyper-IgM Syndrome,Hyper-IgM Syndrome 2,Hyper-IgM Syndrome 3,Hyper-IgM Syndrome 5,Immunodeficiency with Hyper-IgM Syndrome,Immunodeficiency with Hyper-IgM, Type 2,Immunodeficiency with Hyper-IgM, Type 3,Immunodeficiency with Hyper-IgM, Type 5,HIGM2 Syndromes,HIGM3 Syndromes,HIGM5 Syndromes,Hyper IgM Immunodeficiency Syndrome,Hyper IgM Immunodeficiency Syndrome Type 2,Hyper IgM Immunodeficiency Syndrome Type 3,Hyper IgM Immunodeficiency Syndrome Type 5,Hyper IgM Immunodeficiency Syndrome, Type 2,Hyper IgM Immunodeficiency Syndrome, Type 3,Hyper IgM Immunodeficiency Syndrome, Type 5,Hyper IgM Syndrome,Hyper IgM Syndrome 2,Hyper IgM Syndrome 3,Hyper IgM Syndrome 5,Hyper-IgM Immunodeficiency Syndromes,Hyper-IgM Syndrome 5s,Hyper-IgM Syndromes,Immunodeficiency Syndrome, Hyper-IgM,Immunodeficiency Syndromes, Hyper-IgM,Immunodeficiency with Hyper IgM Syndrome,Immunodeficiency with Hyper IgM, Type 2,Immunodeficiency with Hyper IgM, Type 3,Immunodeficiency with Hyper IgM, Type 5,Syndrome, Hyper-IgM Immunodeficiency,Syndromes, Hyper-IgM Immunodeficiency
D027041 Somatic Hypermutation, Immunoglobulin A programmed mutation process whereby changes are introduced to the nucleotide sequence of immunoglobulin gene DNA during development. Hypermutation, Somatic, Immunoglobulin,Ig Somatic Hypermutation,Immunoglobulin Somatic Hypermutation,Somatic Hypermutation, Ig,Hypermutation, Ig Somatic,Hypermutation, Immunoglobulin Somatic,Hypermutations, Ig Somatic,Hypermutations, Immunoglobulin Somatic,Ig Somatic Hypermutations,Immunoglobulin Somatic Hypermutations,Somatic Hypermutations, Ig,Somatic Hypermutations, Immunoglobulin

Related Publications

Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
May 2010, Clinical immunology (Orlando, Fla.),
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
July 2012, Arthritis research & therapy,
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
June 2012, Frontiers in bioscience (Landmark edition),
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
January 1993, Annual review of immunology,
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
August 2011, Immunology letters,
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
January 2007, European journal of immunology,
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
November 2010, The Journal of biological chemistry,
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
March 2007, The Journal of experimental medicine,
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
March 2003, The Journal of experimental medicine,
Anne Durandy, and Nadine Taubenheim, and Sophie Peron, and Alain Fischer
February 1986, Immunological reviews,
Copied contents to your clipboard!